Back to Search Start Over

Belgian recommendations on ANA, anti-dsDNA and anti-ENA antibody testing

Authors :
Van Blerk, Marjan
Van Campenhout, Christel M.
Coucke, Wim
Van De Walle, Philippe
Bossuyt, Xavier
Humbel, René
Mewis, Alex
Servais, Geneviève
Tomasi, Jean-Paul
Van Hoovels, Lieve
Vercammen, Martine J.
Damoiseaux, Jan G M C J.
Van Blerk, Marjan
Van Campenhout, Christel M.
Coucke, Wim
Van De Walle, Philippe
Bossuyt, Xavier
Humbel, René
Mewis, Alex
Servais, Geneviève
Tomasi, Jean-Paul
Van Hoovels, Lieve
Vercammen, Martine J.
Damoiseaux, Jan G M C J.
Source :
Acta clinica Belgica (Ed. multilingue), 69 (2
Publication Year :
2014

Abstract

Autoantibodies to nuclear antigens, i.e. antinuclear antibodies (ANA), antibodies to double-stranded DNA (dsDNA) and extractable nuclear antigens (ENA), are useful as diagnostic markers for a variety of autoimmune diseases. In March 2010, the Belgian national External Quality Assessment Scheme sent a questionnaire on ANA, anti-dsDNA and anti-ENA antibody testing designed by the Dutch EASI (European Autoimmunity Standardization Initiative) team, to all clinical laboratories performing ANA testing. Virtually all laboratories completed the questionnaire (97.7%, 127/130). This paper discusses the results of this questionnaire and provides valuable information on the state-of-the-art of ANA, anti-dsDNA and anti-ENA antibody testing as practiced in the Belgian laboratories. In addition, this work presents practical recommendations developed by the members of the advisory board of the scheme as a result of the outcome of this study. © 2014 Acta Clinica Belgica.<br />SCOPUS: ar.j<br />info:eu-repo/semantics/published

Details

Database :
OAIster
Journal :
Acta clinica Belgica (Ed. multilingue), 69 (2
Notes :
No full-text files, English
Publication Type :
Electronic Resource
Accession number :
edsoai.ocn908363337
Document Type :
Electronic Resource